Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00449904
Status:
COMPLETED
Last Update Posted:
2014-10-24
First Post:
2007-03-19
Brief Title:
Open-Label Phase III Long-Term Safety Trial of Liprotamase
Sponsor:
Anthera Pharmaceuticals
Organization:
Anthera Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Exocrine Pancreatic Insufficiency |
| Cystic Fibrosis |
Keywords:
| Name | View |
|---|---|
| Cystic fibrosis-related exocrine pancreatic insufficiency | View |